Based on recent data, Kalaris Therapeutics Inc (KLRS) shows an Average True Range (ATR) of 0.97 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 62.67K, indicating liquidity. These fundamental metrics provide insight into KLRS's underlying financial health and market activity.
| ATR | 0.97 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 62.67K |
| Avg Vol (10 Days) | 77.64K |
Kalaris Therapeutics Inc (KLRS) technical indicators as of April 16, 2026: the SMA 20 is 10.81%, SMA 50 at 12.87%, and SMA 200 at 96.23%. The RSI 14 value is 57.28, suggesting its current momentum. These technical analysis signals help assess KLRS's price trends and potential future movements.
| SMA 20 | 10.81% |
| SMA 50 | 12.87% |
| SMA 200 | 96.23% |
| RSI 14 | 57.28 |
Kalaris Therapeutics Inc (KLRS) stock performance overview as of April 16, 2026: The 52-week high is $11.22 (currently -18.14% below), and the 52-week low is $2.14 (currently 393.46% above). Over the past year, KLRS's performance is 9%, compared to the S&P 500's 25.19% change.
| 52-Week High | 11.22 |
| 52-Week High Chg | -18.14% |
| 52-Week Low | 2.14 |
| 52-Week Low Chg | +393.46% |
| S&P 500 52-Week Chg | 25.19% |
According to market data, Kalaris Therapeutics Inc (KLRS) stock's recent performance metrics show that over the last month, KLRS is -5.85%, with a Year-to-Date (YTD) performance of 16.23%. Over the past year, the stock has seen a 9% change. These figures summarize KLRS's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 7.14 | 9.29 | 11.22 | 11.22 | 11.22 | 11.22 |
| Low | 5.66 | 5.24 | 5.24 | 4.27 | 2.14 | 5.24 |
| Performance | +10.97% | -5.85% | +111.88% | +305.37% | +9.00% | +16.23% |
According to current financial data, KLRS stock's P/E (TTM) ratio is -3.05, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for KLRS, including P/S (N/A), P/B (1.68), and P/FCF (-2.51), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | KLRS | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -3.05 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 1.68 | 4.71 | 0.29 | 4.95 |
| P/FCF (TTM) | -2.51 | -0.88 | -554.58 | 34.42 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep